Medical Care Technologies Develops Patent-Pending AI Platform for Smartphone-Based Health Screening
核心洞察
Medical Care Technologies Inc. (搜索) announced development of a patent-pending AI health platform capable of early detection for mental health conditions, wound infections, skin cancer (搜索), and disease risk through smartphones.
The multi-vertical platform uses advanced deep learning, temporal image analysis, and affective computing to identify health indicators without specialized hardware or clinical visits.
The company targets four core AI verticals addressing markets valued collectively in the trillions, with first integrated beta consumer app expected in 2026.
Medical Care Technologies Inc. (搜索) (OTC PINK:MDCE) announced a major technological milestone with the development of its patent-pending AI health platform (U.S. Provisional Patent Application No. 63/854,935), engineered to bring real-time diagnostic intelligence directly to smartphones. The system represents a breakthrough in mobile health screening by enabling early detection of high-risk medical conditions without requiring specialized hardware, clinical visits, or expensive imaging devices.
Built on advanced deep learning, temporal image analysis, and affective computing, MDCE's platform is designed to identify early health indicators with precision previously limited to clinical environments. The company is actively developing four core AI verticals targeting rapidly growing markets valued collectively in the trillions.
"Our mission is to make proactive health screening not only accessible, but effortless," said Marshall Perkins, CEO of Medical Care Technologies Inc. (搜索) "If we can give people the ability to detect risk earlier-whether it's melanoma (搜索), infection, or silent mental health decline-then we unlock a new era of preventative, data-driven healthcare. This is not the future of diagnostics; it is the beginning of a new standard of care delivered through everyday technology."
Multi-Vertical AI Healthcare Platform
MDCE's platform aims to transform how patients approach preventative care through four distinct AI-powered screening capabilities:
AI Mental Health Screening
The system uses high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to identify early signs of anxiety (搜索), depression (搜索), and PTSD (搜索). This technology supports a digital mental health market already exceeding $400 billion globally. The AI Mental Health Tracker operates seamlessly through smartphones and webcams, providing scalable, cost-effective access to real-time mental health diagnostics worldwide.
"Mental health remains one of the most underserved areas in global healthcare," said Marshall Perkins III. "Our AI solution has the potential to revolutionize early detection, improve access, and dramatically reduce risk."
AI Wound Monitoring
The platform analyzes sequential imaging for infection risk, tissue deterioration, and healing progression, impacting the global chronic wound care market projected to surpass $30 billion by 2030.
AI Skin Cancer Screening
The system employs full-body lesion mapping, 3D indexing, and temporal skin-change detection to enable population-scale early melanoma (搜索) awareness within a $15+ billion dermatology diagnostics market.
AI Health Risk Estimator
Using facial biometrics, tonal gradient analysis, and multimodal AI, the platform predicts disease predisposition and longevity risk, aligning with the rapidly expanding $4 trillion preventative and precision health sector.
Commercial Timeline and Market Position
MDCE expects to release its first integrated beta consumer app in 2026, marking the company's transition into commercial deployment. The global mental health market is valued at more than $400 billion and is expected to accelerate due to increased demand for digital therapeutics. By providing a non-invasive, AI-driven screening tool, MDCE is positioned to capture significant market share across telehealth, education, military, and workplace wellness programs.
The company plans to integrate the AI Mental Health Tracker into its multi-vertical health platform, with the beta app launch targeted for 2026. The proprietary platform will leverage advanced neural networks to uncover subclinical signs of psychological distress often missed by traditional screenings.
Medical Care Technologies Inc. (搜索) is developing AI-powered diagnostic and preventative health solutions designed to make early health awareness accessible worldwide. Through proprietary deep learning models and patent-pending mobile screening technology, the company is building a scalable ecosystem capable of transforming smartphones into powerful diagnostic tools for consumers, providers, and payers.